AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it has been named a 2024 Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program. This is the second year in a row that AIS Healthcare has been recognized as a Pioneer by URAC for promoting trust in the quality of care delivered through performance measurement activities.
Health Technology Insights: Zentiva And Lupin Sign License And Supply Agreement For TNF Alpha Inhibitor Biosimilar Medicine
To be recognized with the Pioneer in Performance Measurement Award, an organization is required to make key contributions to advance performance measurements and participate in activities that go beyond the mandatory reporting requirements, such as submission of exploratory measures, all with the purpose of helping improve the health and well-being of the populations being served.
URAC is one of the nation’s leading independent health care accreditation organizations, with certification programs that set the highest standards in quality and safety.
“We are honored to have been named a 2024 Pioneer by URAC,” said Simon Castellanos, AIS Healthcare CEO. “This recognition, for the second year in a row, is a testament to the dedication of our entire company to put patient safety first. I could not be prouder of this team and their unwavering commitment to ensuring quality, sterility, and excellence across all our pharmacy operations.
Health Technology Insights: Actithera Raises $75.5 Million to Advance Precision Radioligand Therapy
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients.
AIS Healthcare is also dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers.
Health Technology Insights: XRP Healthcare Names Anna Skowron CFO Before TSXV Listing
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source : businesswire
